<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Campden-Bri on Bioecon</title><link>https://en.bioecon.ru/companies/campden-bri/</link><description>Recent content in Campden-Bri on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Sun, 26 Jul 2026 00:10:24 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/campden-bri/index.xml" rel="self" type="application/rss+xml"/><item><title>Novel food approval-as-a-service (EU/UK/SG)</title><link>https://en.bioecon.ru/technology/novel-food-approval-as-a-service-eu-uk-sg/</link><pubDate>Sat, 25 Jul 2026 17:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/novel-food-approval-as-a-service-eu-uk-sg/</guid><description>Consultancies that carry a new food ingredient through pre-market authorisation — EFSA novel food dossiers, UK FSA filings that no longer follow the EU automatically, US GRAS notifications and Singapore submissions — a service defined by the fact that the same ingredient now needs separate dossiers per jurisdiction.</description></item></channel></rss>